
Ep 83: Guest Megan Othus and Time of Day Administration
James and Sapna welcome Megan Othus, Professor of Biostatistics at the Fred Hutch Cancer Center and one of the key statisticians at SWOG.Megan talks about growing up in the PNW and going East to get b...
24 Juni 40min

Ep 82: Best of ASCO: 2026
In this episode, James & Sapna tease the size of ASCO and ESMO and number of simultaneous publications.They review the most impactful melanoma and Merkel cell carcinoma presentations from ASCO 2026, f...
13 Juni 1h 4min

Live from ASCO 2026: a preview
James & Sapna sent a brief message from ASCO 2026 about what they are looking forward to hearing at the meeting.OptimUM-02ADAMKN-942Neoadjuvant pilot studies... and more
1 Juni 6min

Ep 81: IGNYTE trial (RP1 + nivo)
SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...
13 Feb 32min

Ep 80: 2025 Holiday Special
SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...
30 Dec 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up
SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...
29 Dec 202536min

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)
SummarySo many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib...
29 Dec 202537min




















